Larina Tzu-Wei Shen
4PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 04, 2024
Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.Kazumasa Oya, Yoshiyuki Nakamura, Larina Tzu-Wei Shen
|Jan 17, 2023
Virtual-freezing fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation and antibody labeling for detecting all forms of circulating tumor cells.Hiroki Matsumura, Larina Tzu-Wei Shen, Akihiro Isozaki
|Oct 27, 2022
Plasma Exchange May Enhance Antitumor Effects by Removal of Soluble Programmed Death-Ligand 1 and Extracellular Vesicles: Preliminary Study.Kazumasa Oya, Larina Tzu-Wei Shen, Kazushi Maruo
|Apr 13, 2017
The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB.Yukari Okita, Minori Kimura, Rudy Xie
Pageof 1
Frequent Collaborators
2 joint publications
Kazumasa Oya
1 joint publications
Yukari Okita
1 joint publications
Minori Kimura
1 joint publications
Rudy Xie
1 joint publications
Chen Chen
1 joint publications
Hiroyuki Suzuki
1 joint publications
Masafumi Muratani
1 joint publications
Masao Saitoh
1 joint publications
Kentaro Semba
1 joint publications
Carl-Henrik Heldin
